FDA 483 - Chartwell Pharmaceuticals Amityville, LLC - February 13, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Hi-Tech Pharmacal Co. Inc., an AKORN Company, in Amityville, NY, revealed significant deficiencies in their sterile and non-sterile drug manufacturing operations. Observations included inadequate equipment maintenance records, improper aseptic processing practices, failure to follow the written stability testing program, and insufficient testing of containers and closures. These issues led to numerous customer complaints regarding product quality.
ID · d1cdf69f-9f0a-4fe6-94a0-1cbc864a8338